S

Stryker

Manufactures orthopedic and surgical medical devices

Senior Manager - Government Affairs & Market Access

Full-TimeUpdated on 10/15/2026
No salary listed
Senior
Bachelor's, Master's
Johannesburg, South Africa
HybridThree days per week on-site in the Johannesburg office. Travel is approximately 15–20%, including occasional travel within EMEA or globally.
Growth & MarketingProduct Marketing

About the job

Requirements
  • A bachelor's degree in science, medical, technical, political science, business, or a related field is required.
  • At least 6 years of relevant experience in government affairs, market access, reimbursement, or healthcare policy is required.
  • Strong experience in reimbursement strategy and market access within the medical device or pharmaceutical industry is required.
  • A proven track record developing reimbursement strategies and securing approvals from payers, funders, or hospital groups is required.
  • Strong stakeholder management, communication, negotiation, analytical, and project management skills are required.
  • Fluent English language skills are required.
Responsibilities
  • Lead the South Africa government affairs and market access strategy, aligned with country and business priorities and focused on enabling commercialization and patient access.
  • Build strategic relationships with government officials, policymakers, trade associations, payers, reimbursement organizations, hospital groups, key opinion leaders, medical specialty societies, and other relevant stakeholders.
  • Drive reimbursement strategies and submissions for Stryker medical device technologies, including new product introductions, with the goal of securing approvals from funders and key hospital groups.
  • Develop evidence-based value propositions using clinical and health economic data to demonstrate the value of Stryker technologies and support reimbursement and commercial objectives.
  • Identify and lead market access and government affairs projects that address policy developments, reimbursement opportunities, and barriers to product adoption.
  • Advise business and functional leaders on policy, reimbursement, health economics, and market access considerations, integrating these into business and commercialization strategies.
  • Monitor and influence relevant healthcare policy and reimbursement developments in South Africa, proactively identifying risks and opportunities for the business.
  • Strengthen government affairs and market access capabilities across South Africa by partnering cross-functionally and cross-divisionally and sharing market access insights, best practices, and strategic guidance.
Desired Qualifications
  • Established relationships with South African payers, reimbursement bodies, healthcare authorities, hospital groups, or key opinion leaders.
  • Experience engaging with trade associations and senior government or policy stakeholders.

About the company

Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
  • Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
  • Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.

What critics are saying

  • Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
  • Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
  • Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.

What makes Stryker unique

  • Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
  • Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
  • Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Medical & prescription plans
  • Supplemental health benefits
  • Flexible Spending accounts
  • Employee Assistance Program
  • Short-term & long-term disability
  • Tuition reimbursement
  • 401(k) plan
  • Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 14th, 2026
Stryker wins FDA clearance for Sonopet 3 ultrasonic bone and tissue removal platform

Stryker has received US Food and Drug Administration (FDA) 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The company announced the news on October 14, 2026. Stryker developed the platform with input from hundreds of surgeons. It offers more power, precision and versatility, along with two technologies: RISE, which connects the surgical workflow, and Pulse Control, which helps regulate the resection of hard and soft tissues. "They told us they wanted more power, improved ergonomics and enhanced integration," said Mitch Foley, vice president and general manager of Stryker's Neurosurgical business. The first clinical cases are expected to begin in October. A full commercial launch is planned for later this fall.

Yahoo Finance
Oct 12th, 2026
Stryker shares fall 20% in six months despite 9.2% organic growth and $25.84B revenue

Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.

Seeking Alpha
Oct 12th, 2026
Stryker to invest $400M in CMR Surgical, with option to buy the robotics maker outright

Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.

PR Newswire
Oct 5th, 2026
Stryker launches Mako 4 SmartRobotics in India after 2.5M procedures globally

Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.

Stryker Corporation
Sep 20th, 2026
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.” The addition of an IVL platform will strengthen Stryker’s impact in peripheral vascular solutions. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products